

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 7.38003341 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.38003341 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.38003341 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.38003341 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 7.38003341 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 7.38003341 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.30429813 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 5.24295419 |
| 9 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.10152777 |
| 10 | positive regulation of interferon-alpha production (GO:0032727) | 5.02527206 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.81602826 |
| 12 | regulation of interferon-alpha production (GO:0032647) | 4.80828486 |
| 13 | microglial cell activation (GO:0001774) | 4.67780685 |
| 14 | response to host immune response (GO:0052572) | 4.60588326 |
| 15 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.60588326 |
| 16 | virion attachment to host cell (GO:0019062) | 4.51620720 |
| 17 | adhesion of symbiont to host cell (GO:0044650) | 4.51620720 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.49103436 |
| 19 | extracellular fibril organization (GO:0043206) | 4.48330122 |
| 20 | barbed-end actin filament capping (GO:0051016) | 4.33895446 |
| 21 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.19823345 |
| 22 | response to host (GO:0075136) | 4.19823345 |
| 23 | response to host defenses (GO:0052200) | 4.19823345 |
| 24 | collagen fibril organization (GO:0030199) | 4.19080654 |
| 25 | cell migration involved in heart development (GO:0060973) | 4.12336392 |
| 26 | response to peptidoglycan (GO:0032494) | 4.10336192 |
| 27 | fibril organization (GO:0097435) | 4.07944948 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 4.05182298 |
| 29 | regulation of mononuclear cell migration (GO:0071675) | 4.03344150 |
| 30 | macrophage activation (GO:0042116) | 3.96490096 |
| 31 | endodermal cell differentiation (GO:0035987) | 3.88165140 |
| 32 | regulation of cholesterol storage (GO:0010885) | 3.81311254 |
| 33 | detection of molecule of bacterial origin (GO:0032490) | 3.68476136 |
| 34 | stress fiber assembly (GO:0043149) | 3.64614823 |
| 35 | apoptotic cell clearance (GO:0043277) | 3.62268948 |
| 36 | * regulation of integrin-mediated signaling pathway (GO:2001044) | 3.61936726 |
| 37 | substrate-dependent cell migration (GO:0006929) | 3.61358849 |
| 38 | blood vessel maturation (GO:0001955) | 3.54836248 |
| 39 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.53443718 |
| 40 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.51053869 |
| 41 | I-kappaB phosphorylation (GO:0007252) | 3.46641979 |
| 42 | protein localization to endosome (GO:0036010) | 3.46636485 |
| 43 | chondrocyte proliferation (GO:0035988) | 3.43218733 |
| 44 | positive regulation of interferon-beta production (GO:0032728) | 3.40485886 |
| 45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.40399608 |
| 46 | skin morphogenesis (GO:0043589) | 3.40181297 |
| 47 | eosinophil chemotaxis (GO:0048245) | 3.38110129 |
| 48 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.36227629 |
| 49 | low-density lipoprotein particle clearance (GO:0034383) | 3.32401192 |
| 50 | protein heterotrimerization (GO:0070208) | 3.32286253 |
| 51 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.30854780 |
| 52 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.29417139 |
| 53 | cellular response to interferon-alpha (GO:0035457) | 3.28496242 |
| 54 | cell adhesion mediated by integrin (GO:0033627) | 3.26908021 |
| 55 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.26440625 |
| 56 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.25681571 |
| 57 | positive regulation of macrophage cytokine production (GO:0060907) | 3.24195582 |
| 58 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.20712576 |
| 59 | myeloid cell activation involved in immune response (GO:0002275) | 3.20103002 |
| 60 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.18238574 |
| 61 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.17414764 |
| 62 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.17301302 |
| 63 | response to magnesium ion (GO:0032026) | 3.17171887 |
| 64 | toxin transport (GO:1901998) | 3.13050294 |
| 65 | venous blood vessel morphogenesis (GO:0048845) | 3.12678759 |
| 66 | collagen metabolic process (GO:0032963) | 3.12131381 |
| 67 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.11859669 |
| 68 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.10141047 |
| 69 | negative regulation of granulocyte differentiation (GO:0030853) | 3.09525803 |
| 70 | positive regulation of antigen processing and presentation (GO:0002579) | 3.09338127 |
| 71 | monocyte chemotaxis (GO:0002548) | 3.04532461 |
| 72 | phagocytosis, engulfment (GO:0006911) | 3.02456650 |
| 73 | negative regulation of platelet activation (GO:0010544) | 3.02067636 |
| 74 | extracellular matrix assembly (GO:0085029) | 3.01875023 |
| 75 | negative regulation of mast cell activation (GO:0033004) | 3.01636051 |
| 76 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.00896743 |
| 77 | collagen catabolic process (GO:0030574) | 2.99904054 |
| 78 | respiratory burst (GO:0045730) | 2.99406960 |
| 79 | regulation of macrophage chemotaxis (GO:0010758) | 2.94495298 |
| 80 | * pinocytosis (GO:0006907) | 2.94415953 |
| 81 | platelet degranulation (GO:0002576) | 2.94150251 |
| 82 | kidney mesenchyme development (GO:0072074) | 2.94099137 |
| 83 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.93946243 |
| 84 | cellular extravasation (GO:0045123) | 2.91989233 |
| 85 | positive regulation of extracellular matrix organization (GO:1903055) | 2.91598159 |
| 86 | hyaluronan catabolic process (GO:0030214) | 2.91158259 |
| 87 | eosinophil migration (GO:0072677) | 2.90664571 |
| 88 | regulation of mast cell degranulation (GO:0043304) | 2.90135169 |
| 89 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.89024080 |
| 90 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.88697781 |
| 91 | regulation of macrophage cytokine production (GO:0010935) | 2.87655435 |
| 92 | wound healing, spreading of epidermal cells (GO:0035313) | 2.87086551 |
| 93 | granulocyte activation (GO:0036230) | 2.87001816 |
| 94 | type B pancreatic cell proliferation (GO:0044342) | 2.86558189 |
| 95 | keratan sulfate catabolic process (GO:0042340) | 2.85028853 |
| 96 | negative regulation of lipid storage (GO:0010888) | 2.84735583 |
| 97 | metanephric mesenchyme development (GO:0072075) | 2.84533928 |
| 98 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.84288272 |
| 99 | positive regulation of p38MAPK cascade (GO:1900745) | 2.83995698 |
| 100 | endothelium development (GO:0003158) | 2.82720236 |
| 101 | B cell mediated immunity (GO:0019724) | 2.81975759 |
| 102 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.80036040 |
| 103 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.79489657 |
| 104 | positive regulation of leukocyte degranulation (GO:0043302) | 2.79403423 |
| 105 | multicellular organismal catabolic process (GO:0044243) | 2.79154686 |
| 106 | folic acid transport (GO:0015884) | 2.78972679 |
| 107 | melanin biosynthetic process (GO:0042438) | 2.78932766 |
| 108 | response to muramyl dipeptide (GO:0032495) | 2.77360609 |
| 109 | lymphocyte chemotaxis (GO:0048247) | 2.76185826 |
| 110 | multicellular organismal metabolic process (GO:0044236) | 2.75466500 |
| 111 | response to thyroid hormone (GO:0097066) | 2.75387978 |
| 112 | neutrophil activation (GO:0042119) | 2.75298404 |
| 113 | negative regulation of focal adhesion assembly (GO:0051895) | 2.75234607 |
| 114 | negative regulation of cell junction assembly (GO:1901889) | 2.75234607 |
| 115 | negative regulation of adherens junction organization (GO:1903392) | 2.75234607 |
| 116 | extracellular matrix disassembly (GO:0022617) | 2.74890898 |
| 117 | positive regulation of mast cell activation (GO:0033005) | 2.74060183 |
| 118 | cellular response to vitamin (GO:0071295) | 2.73371555 |
| 119 | lipoprotein transport (GO:0042953) | 2.71296058 |
| 120 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.71128665 |
| 121 | angiogenesis involved in wound healing (GO:0060055) | 2.69704536 |
| 122 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.69296597 |
| 123 | platelet aggregation (GO:0070527) | 2.69080138 |
| 124 | regulation of monocyte chemotaxis (GO:0090025) | 2.68996428 |
| 125 | glycosphingolipid catabolic process (GO:0046479) | 2.68851148 |
| 126 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.68729433 |
| 127 | positive regulation of fibroblast migration (GO:0010763) | 2.67642759 |
| 128 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.67401631 |
| 129 | regulation of leukocyte degranulation (GO:0043300) | 2.67296113 |
| 130 | pericardium development (GO:0060039) | 2.65977816 |
| 131 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.65596973 |
| 132 | mannose metabolic process (GO:0006013) | 2.65484234 |
| 133 | regulation of extracellular matrix disassembly (GO:0010715) | 2.64813417 |
| 134 | positive regulation of bone remodeling (GO:0046852) | 2.64631975 |
| 135 | positive regulation of bone resorption (GO:0045780) | 2.64631975 |
| 136 | membrane raft organization (GO:0031579) | 2.64296987 |
| 137 | glomerular basement membrane development (GO:0032836) | 2.64104902 |
| 138 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.62303906 |
| 139 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.61463644 |
| 140 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.61042687 |
| 141 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.60032110 |
| 142 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.59760299 |
| 143 | response to interferon-alpha (GO:0035455) | 2.59651206 |
| 144 | regulation of integrin activation (GO:0033623) | 2.58551364 |
| 145 | regulation of mast cell activation (GO:0033003) | 2.58335699 |
| 146 | regulation of antigen processing and presentation (GO:0002577) | 2.57929335 |
| 147 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.57875424 |
| 148 | phagocytosis, recognition (GO:0006910) | 2.56858229 |
| 149 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.56846172 |
| 150 | regulation of smooth muscle cell migration (GO:0014910) | 2.56456093 |
| 151 | response to laminar fluid shear stress (GO:0034616) | 2.56161268 |
| 152 | positive regulation of osteoblast proliferation (GO:0033690) | 2.56044931 |
| 153 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.55398480 |
| 154 | bone trabecula formation (GO:0060346) | 2.54886893 |
| 155 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.53953937 |
| 156 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.53823928 |
| 157 | regulation of interferon-beta production (GO:0032648) | 2.52825680 |
| 158 | basement membrane organization (GO:0071711) | 2.52079923 |
| 159 | membrane invagination (GO:0010324) | 2.51287861 |
| 160 | endothelial cell morphogenesis (GO:0001886) | 2.50948594 |
| 161 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.50510446 |
| 162 | tooth mineralization (GO:0034505) | 2.50491412 |
| 163 | positive regulation of chemokine production (GO:0032722) | 2.50167898 |
| 164 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.50063018 |
| 165 | positive regulation of T cell apoptotic process (GO:0070234) | 2.50061560 |
| 166 | regulation of platelet activation (GO:0010543) | 2.50017084 |
| 167 | adhesion of symbiont to host (GO:0044406) | 2.49678552 |
| 168 | cortical actin cytoskeleton organization (GO:0030866) | 2.48943827 |
| 169 | positive regulation of lymphocyte migration (GO:2000403) | 2.48927726 |
| 170 | lymphangiogenesis (GO:0001946) | 2.48245228 |
| 171 | negative regulation of protein localization to cell surface (GO:2000009) | 2.47906726 |
| 172 | negative regulation of monooxygenase activity (GO:0032769) | 2.44644272 |
| 173 | protein localization to cell surface (GO:0034394) | 2.43986777 |
| 174 | extracellular matrix organization (GO:0030198) | 2.43822417 |
| 175 | extracellular structure organization (GO:0043062) | 2.42823184 |
| 176 | * negative regulation of protein localization to plasma membrane (GO:1903077) | 2.42200802 |
| 177 | hypotonic response (GO:0006971) | 2.42030132 |
| 178 | extracellular regulation of signal transduction (GO:1900115) | 2.39863627 |
| 179 | extracellular negative regulation of signal transduction (GO:1900116) | 2.39863627 |
| 180 | melanin metabolic process (GO:0006582) | 2.39652554 |
| 181 | endosome to melanosome transport (GO:0035646) | 2.37499393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.10918439 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.09465080 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.50409514 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.45146506 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.18364445 |
| 6 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.01316525 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.65210638 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.15134223 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.89753525 |
| 10 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.74173566 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.69963706 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.68325288 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.56729832 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.49703345 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.38890598 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.38850879 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.31540549 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.28868095 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.24583190 |
| 20 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.15827397 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.15065119 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.11988043 |
| 23 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.11818377 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.02772537 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.97926859 |
| 26 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.96150131 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87875183 |
| 28 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.81459328 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.80670892 |
| 30 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.80322395 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.78397918 |
| 32 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.78101253 |
| 33 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.75556281 |
| 34 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.74230884 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.73730855 |
| 36 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.67450824 |
| 37 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.66576965 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60454701 |
| 39 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.60067516 |
| 40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.59103554 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.49117866 |
| 42 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.48700506 |
| 43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47563311 |
| 44 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42986661 |
| 45 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42219245 |
| 46 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.40453207 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.38001116 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37609161 |
| 49 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.37314660 |
| 50 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.37268484 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36320254 |
| 52 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.35847610 |
| 53 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.34485432 |
| 54 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.33100702 |
| 55 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.33100702 |
| 56 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.32979306 |
| 57 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32527737 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31805311 |
| 59 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.30493736 |
| 60 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30003656 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28830555 |
| 62 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.28670662 |
| 63 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.27733541 |
| 64 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.27527540 |
| 65 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.26239256 |
| 66 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.26019666 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24138524 |
| 68 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.23338758 |
| 69 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.22016510 |
| 70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21746906 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20832429 |
| 72 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20305046 |
| 73 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.19630222 |
| 74 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.19619638 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19522254 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15379458 |
| 77 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15093163 |
| 78 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.14732307 |
| 79 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.14726598 |
| 80 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.14726598 |
| 81 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.13630102 |
| 82 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13267356 |
| 83 | MAF_26560356_Chip-Seq_TH1_Human | 1.09678613 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09646935 |
| 85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09646935 |
| 86 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09478898 |
| 87 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.07434657 |
| 88 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06907343 |
| 89 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.06459523 |
| 90 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05306468 |
| 91 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.04949916 |
| 92 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04916910 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04303287 |
| 94 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.03812209 |
| 95 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02479042 |
| 96 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02356100 |
| 97 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02119748 |
| 98 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01951926 |
| 99 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01283532 |
| 100 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01106169 |
| 101 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01004463 |
| 102 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.99905439 |
| 103 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.99796304 |
| 104 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.99551371 |
| 105 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99538419 |
| 106 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99461296 |
| 107 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98465547 |
| 108 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.98151936 |
| 109 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.97577867 |
| 110 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.97484612 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97158121 |
| 112 | MYB_26560356_Chip-Seq_TH2_Human | 0.96287007 |
| 113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95941035 |
| 114 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94703032 |
| 115 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94596919 |
| 116 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93861042 |
| 117 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.92247405 |
| 118 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.91683422 |
| 119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91258517 |
| 120 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90931032 |
| 121 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.90485205 |
| 122 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.89920098 |
| 123 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.89130424 |
| 124 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88462379 |
| 125 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.88066024 |
| 126 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.87102970 |
| 127 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.87060465 |
| 128 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86384162 |
| 129 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85827899 |
| 130 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85658708 |
| 131 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.85271203 |
| 132 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.84625418 |
| 133 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83802016 |
| 134 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83614572 |
| 135 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.83567775 |
| 136 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.81645211 |
| 137 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80801334 |
| 138 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80637634 |
| 139 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.79679647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.15440470 |
| 2 | MP0009840_abnormal_foam_cell | 3.38027975 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.29277350 |
| 4 | MP0000569_abnormal_digit_pigmentation | 2.91852728 |
| 5 | MP0003950_abnormal_plasma_membrane | 2.89541671 |
| 6 | MP0003303_peritoneal_inflammation | 2.88923999 |
| 7 | MP0003436_decreased_susceptibility_to | 2.86983857 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.81558433 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.79458246 |
| 10 | MP0002419_abnormal_innate_immunity | 2.51320012 |
| 11 | MP0006082_CNS_inflammation | 2.48780174 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.43199624 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.36632238 |
| 14 | MP0005171_absent_coat_pigmentation | 2.29470679 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.21859635 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.20932739 |
| 17 | MP0002877_abnormal_melanocyte_morpholog | 2.10172939 |
| 18 | MP0000343_altered_response_to | 2.09273784 |
| 19 | MP0001533_abnormal_skeleton_physiology | 2.00907010 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.99078151 |
| 21 | MP0001958_emphysema | 1.97395967 |
| 22 | MP0003724_increased_susceptibility_to | 1.88070659 |
| 23 | MP0003690_abnormal_glial_cell | 1.75194165 |
| 24 | MP0009384_cardiac_valve_regurgitation | 1.74123188 |
| 25 | MP0008004_abnormal_stomach_pH | 1.73779576 |
| 26 | MP0000604_amyloidosis | 1.72996739 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.72345539 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.72118439 |
| 29 | MP0003448_altered_tumor_morphology | 1.67674909 |
| 30 | MP0005025_abnormal_response_to | 1.65683641 |
| 31 | MP0005387_immune_system_phenotype | 1.64012068 |
| 32 | MP0001790_abnormal_immune_system | 1.64012068 |
| 33 | MP0005257_abnormal_intraocular_pressure | 1.63747785 |
| 34 | MP0009278_abnormal_bone_marrow | 1.63014425 |
| 35 | MP0009785_altered_susceptibility_to | 1.62203913 |
| 36 | MP0004510_myositis | 1.59630977 |
| 37 | MP0003828_pulmonary_edema | 1.57039132 |
| 38 | MP0002998_abnormal_bone_remodeling | 1.55499106 |
| 39 | MP0004019_abnormal_vitamin_homeostasis | 1.55383111 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.50689885 |
| 41 | MP0002896_abnormal_bone_mineralization | 1.49143797 |
| 42 | MP0005275_abnormal_skin_tensile | 1.44274748 |
| 43 | MP0003279_aneurysm | 1.44176796 |
| 44 | MP0005595_abnormal_vascular_smooth | 1.44111845 |
| 45 | MP0005623_abnormal_meninges_morphology | 1.43391285 |
| 46 | MP0005508_abnormal_skeleton_morphology | 1.42474387 |
| 47 | MP0000372_irregular_coat_pigmentation | 1.42220534 |
| 48 | MP0002723_abnormal_immune_serum | 1.39163364 |
| 49 | MP0005408_hypopigmentation | 1.38879293 |
| 50 | MP0000015_abnormal_ear_pigmentation | 1.36165646 |
| 51 | MP0004272_abnormal_basement_membrane | 1.35562788 |
| 52 | MP0001800_abnormal_humoral_immune | 1.32698444 |
| 53 | MP0008469_abnormal_protein_level | 1.30421447 |
| 54 | MP0002405_respiratory_system_inflammati | 1.29418286 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.28088797 |
| 56 | MP0009764_decreased_sensitivity_to | 1.25364086 |
| 57 | MP0001819_abnormal_immune_cell | 1.21879186 |
| 58 | * MP0002136_abnormal_kidney_physiology | 1.21836197 |
| 59 | MP0004947_skin_inflammation | 1.20551932 |
| 60 | MP0002420_abnormal_adaptive_immunity | 1.19774401 |
| 61 | MP0010386_abnormal_urinary_bladder | 1.18732265 |
| 62 | MP0003075_altered_response_to | 1.18556181 |
| 63 | MP0001853_heart_inflammation | 1.18125146 |
| 64 | MP0001756_abnormal_urination | 1.18073201 |
| 65 | MP0005390_skeleton_phenotype | 1.17604037 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 1.14529827 |
| 67 | MP0002060_abnormal_skin_morphology | 1.13737661 |
| 68 | MP0000767_abnormal_smooth_muscle | 1.12988275 |
| 69 | MP0005164_abnormal_response_to | 1.12300232 |
| 70 | MP0005310_abnormal_salivary_gland | 1.11454991 |
| 71 | MP0010352_gastrointestinal_tract_polyps | 1.10919198 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 1.10204147 |
| 73 | MP0005076_abnormal_cell_differentiation | 1.09431913 |
| 74 | MP0003195_calcinosis | 1.08086973 |
| 75 | MP0003091_abnormal_cell_migration | 1.07085819 |
| 76 | MP0005023_abnormal_wound_healing | 1.06680820 |
| 77 | MP0010307_abnormal_tumor_latency | 1.05925918 |
| 78 | MP0006054_spinal_hemorrhage | 1.05542721 |
| 79 | MP0005409_darkened_coat_color | 1.03745704 |
| 80 | MP0002254_reproductive_system_inflammat | 1.02767318 |
| 81 | MP0010368_abnormal_lymphatic_system | 1.02571888 |
| 82 | MP0005166_decreased_susceptibility_to | 1.02203809 |
| 83 | * MP0009643_abnormal_urine_homeostasis | 1.02159357 |
| 84 | MP0001243_abnormal_dermal_layer | 1.00907964 |
| 85 | MP0002933_joint_inflammation | 1.00816873 |
| 86 | MP0002295_abnormal_pulmonary_circulatio | 0.98842304 |
| 87 | MP0001915_intracranial_hemorrhage | 0.98592270 |
| 88 | MP0003795_abnormal_bone_structure | 0.98531494 |
| 89 | MP0002108_abnormal_muscle_morphology | 0.98512080 |
| 90 | MP0004084_abnormal_cardiac_muscle | 0.98318523 |
| 91 | MP0003941_abnormal_skin_development | 0.98161558 |
| 92 | MP0000685_abnormal_immune_system | 0.96744266 |
| 93 | MP0000858_altered_metastatic_potential | 0.94862887 |
| 94 | MP0005503_abnormal_tendon_morphology | 0.94276463 |
| 95 | MP0005671_abnormal_response_to | 0.94019484 |
| 96 | MP0002128_abnormal_blood_circulation | 0.93996652 |
| 97 | MP0009333_abnormal_splenocyte_physiolog | 0.92769711 |
| 98 | MP0004233_abnormal_muscle_weight | 0.92613866 |
| 99 | MP0004883_abnormal_blood_vessel | 0.92479710 |
| 100 | MP0001851_eye_inflammation | 0.90225597 |
| 101 | MP0000751_myopathy | 0.87044699 |
| 102 | MP0000013_abnormal_adipose_tissue | 0.86212049 |
| 103 | MP0000249_abnormal_blood_vessel | 0.86048962 |
| 104 | MP0001849_ear_inflammation | 0.85524325 |
| 105 | * MP0002135_abnormal_kidney_morphology | 0.85089167 |
| 106 | MP0000689_abnormal_spleen_morphology | 0.84160591 |
| 107 | MP0002168_other_aberrant_phenotype | 0.83358956 |
| 108 | MP0000749_muscle_degeneration | 0.83061924 |
| 109 | MP0000465_gastrointestinal_hemorrhage | 0.82809862 |
| 110 | MP0009780_abnormal_chondrocyte_physiolo | 0.82437283 |
| 111 | MP0005174_abnormal_tail_pigmentation | 0.82059306 |
| 112 | MP0010155_abnormal_intestine_physiology | 0.81671023 |
| 113 | MP0003186_abnormal_redox_activity | 0.81392305 |
| 114 | MP0000371_diluted_coat_color | 0.80370448 |
| 115 | MP0006138_congestive_heart_failure | 0.79853637 |
| 116 | MP0004036_abnormal_muscle_relaxation | 0.79587029 |
| 117 | MP0001881_abnormal_mammary_gland | 0.78687949 |
| 118 | MP0001879_abnormal_lymphatic_vessel | 0.78056313 |
| 119 | MP0003183_abnormal_peptide_metabolism | 0.77857568 |
| 120 | MP0005197_abnormal_uvea_morphology | 0.76485154 |
| 121 | MP0001545_abnormal_hematopoietic_system | 0.75485921 |
| 122 | MP0005397_hematopoietic_system_phenotyp | 0.75485921 |
| 123 | MP0005165_increased_susceptibility_to | 0.73467205 |
| 124 | MP0000716_abnormal_immune_system | 0.73434277 |
| 125 | MP0001614_abnormal_blood_vessel | 0.73158043 |
| 126 | MP0000733_abnormal_muscle_development | 0.72907370 |
| 127 | MP0009763_increased_sensitivity_to | 0.72583950 |
| 128 | MP0001542_abnormal_bone_strength | 0.72269891 |
| 129 | MP0002113_abnormal_skeleton_development | 0.72255619 |
| 130 | MP0005332_abnormal_amino_acid | 0.72178056 |
| 131 | MP0002115_abnormal_skeleton_extremities | 0.71458174 |
| 132 | MP0009250_abnormal_appendicular_skeleto | 0.71201911 |
| 133 | MP0000163_abnormal_cartilage_morphology | 0.70379062 |
| 134 | MP0002133_abnormal_respiratory_system | 0.69892910 |
| 135 | MP0005388_respiratory_system_phenotype | 0.69892910 |
| 136 | MP0005193_abnormal_anterior_eye | 0.68115636 |
| 137 | MP0000230_abnormal_systemic_arterial | 0.66072694 |
| 138 | MP0000534_abnormal_ureter_morphology | 0.65713015 |
| 139 | MP0000759_abnormal_skeletal_muscle | 0.65537129 |
| 140 | MP0001299_abnormal_eye_distance/ | 0.58441981 |
| 141 | MP0010030_abnormal_orbit_morphology | 0.54503271 |
| 142 | MP0000003_abnormal_adipose_tissue | 0.53281082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.28599667 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 6.06233387 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 5.78893041 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.32065782 |
| 5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.18722429 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.67725176 |
| 7 | Dysostosis multiplex (HP:0000943) | 4.56517761 |
| 8 | Axonal loss (HP:0003447) | 4.42109366 |
| 9 | Glomerulonephritis (HP:0000099) | 4.35191909 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.28509500 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.16897769 |
| 12 | Disinhibition (HP:0000734) | 4.05562847 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 3.99726065 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.99726065 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.99726065 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.62127271 |
| 17 | Soft skin (HP:0000977) | 3.60332192 |
| 18 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.49982240 |
| 19 | Mucopolysacchariduria (HP:0008155) | 3.48376854 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.48376854 |
| 21 | Ankle contracture (HP:0006466) | 3.38416033 |
| 22 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.33874358 |
| 23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.33874358 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.33874358 |
| 25 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.11567178 |
| 26 | Osteolytic defects of the hand bones (HP:0009699) | 3.11567178 |
| 27 | Myocardial infarction (HP:0001658) | 3.10885772 |
| 28 | Nephritis (HP:0000123) | 3.09229980 |
| 29 | Complement deficiency (HP:0004431) | 3.08985210 |
| 30 | Follicular hyperkeratosis (HP:0007502) | 3.06191674 |
| 31 | Wormian bones (HP:0002645) | 3.05154683 |
| 32 | Prostate neoplasm (HP:0100787) | 3.05052374 |
| 33 | Abnormality of complement system (HP:0005339) | 3.03335819 |
| 34 | Bladder diverticulum (HP:0000015) | 3.00860450 |
| 35 | Hematochezia (HP:0002573) | 2.97721720 |
| 36 | Spinal rigidity (HP:0003306) | 2.95628200 |
| 37 | Dilatation of the ascending aorta (HP:0005111) | 2.94827606 |
| 38 | Premature rupture of membranes (HP:0001788) | 2.93533452 |
| 39 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.89652576 |
| 40 | Thick nail (HP:0001805) | 2.88953192 |
| 41 | Purpura (HP:0000979) | 2.87834185 |
| 42 | Cerebral aneurysm (HP:0004944) | 2.80840927 |
| 43 | Blue sclerae (HP:0000592) | 2.80414456 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 2.77501324 |
| 45 | Type 1 muscle fiber predominance (HP:0003803) | 2.76681776 |
| 46 | Increased mean platelet volume (HP:0011877) | 2.76235326 |
| 47 | Gingivitis (HP:0000230) | 2.75731174 |
| 48 | Pathologic fracture (HP:0002756) | 2.74088060 |
| 49 | Atrophic scars (HP:0001075) | 2.69757146 |
| 50 | Genu recurvatum (HP:0002816) | 2.67212997 |
| 51 | Mitral stenosis (HP:0001718) | 2.63777459 |
| 52 | Broad metatarsal (HP:0001783) | 2.63566423 |
| 53 | Petechiae (HP:0000967) | 2.60051606 |
| 54 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.59470296 |
| 55 | Spontaneous hematomas (HP:0007420) | 2.59118977 |
| 56 | Fragile skin (HP:0001030) | 2.57999924 |
| 57 | Joint stiffness (HP:0001387) | 2.55853716 |
| 58 | Orchitis (HP:0100796) | 2.53430852 |
| 59 | Cervical subluxation (HP:0003308) | 2.52169235 |
| 60 | Hypoplasia of the iris (HP:0007676) | 2.51000472 |
| 61 | Abnormal platelet volume (HP:0011876) | 2.50647575 |
| 62 | Menorrhagia (HP:0000132) | 2.49969255 |
| 63 | Myositis (HP:0100614) | 2.49076380 |
| 64 | Abnormality of dentin (HP:0010299) | 2.46725885 |
| 65 | Agnosia (HP:0010524) | 2.46168363 |
| 66 | Aneurysm (HP:0002617) | 2.42995950 |
| 67 | Mitral valve prolapse (HP:0001634) | 2.41152747 |
| 68 | Vertebral compression fractures (HP:0002953) | 2.39680098 |
| 69 | Progressive visual loss (HP:0000529) | 2.38918771 |
| 70 | Recurrent skin infections (HP:0001581) | 2.38337787 |
| 71 | Bone pain (HP:0002653) | 2.34408270 |
| 72 | Neonatal short-limb short stature (HP:0008921) | 2.33935226 |
| 73 | Peripheral demyelination (HP:0011096) | 2.32668937 |
| 74 | Aortic regurgitation (HP:0001659) | 2.31994245 |
| 75 | Abnormality of the acetabulum (HP:0003170) | 2.29612678 |
| 76 | Prolonged bleeding time (HP:0003010) | 2.29156640 |
| 77 | Conjunctival telangiectasia (HP:0000524) | 2.29005597 |
| 78 | Mediastinal lymphadenopathy (HP:0100721) | 2.28506600 |
| 79 | Slender build (HP:0001533) | 2.25311942 |
| 80 | Periodontitis (HP:0000704) | 2.24355786 |
| 81 | Loss of speech (HP:0002371) | 2.23163568 |
| 82 | Aortic valve stenosis (HP:0001650) | 2.22723963 |
| 83 | Overgrowth (HP:0001548) | 2.21611828 |
| 84 | Pustule (HP:0200039) | 2.21594356 |
| 85 | Nausea (HP:0002018) | 2.20750943 |
| 86 | Shallow orbits (HP:0000586) | 2.20135456 |
| 87 | Increased variability in muscle fiber diameter (HP:0003557) | 2.19440528 |
| 88 | Basal ganglia calcification (HP:0002135) | 2.17696846 |
| 89 | Epistaxis (HP:0000421) | 2.16735058 |
| 90 | Upper motor neuron abnormality (HP:0002127) | 2.15794535 |
| 91 | Hyperextensible skin (HP:0000974) | 2.12835628 |
| 92 | Cardiovascular calcification (HP:0011915) | 2.12224085 |
| 93 | Nuclear cataract (HP:0100018) | 2.10603126 |
| 94 | Elbow flexion contracture (HP:0002987) | 2.10520228 |
| 95 | Joint laxity (HP:0001388) | 2.07770796 |
| 96 | Arterial tortuosity (HP:0005116) | 2.05909701 |
| 97 | Aortic dissection (HP:0002647) | 2.05369285 |
| 98 | Gingival bleeding (HP:0000225) | 2.05276607 |
| 99 | Abnormality of the lumbar spine (HP:0100712) | 2.04441456 |
| 100 | Interstitial pulmonary disease (HP:0006530) | 2.04394013 |
| 101 | Esophageal varix (HP:0002040) | 2.04328568 |
| 102 | Chronic obstructive pulmonary disease (HP:0006510) | 2.04145718 |
| 103 | Obstructive lung disease (HP:0006536) | 2.04145718 |
| 104 | Abnormal delivery (HP:0001787) | 2.03985478 |
| 105 | Apathy (HP:0000741) | 2.02659846 |
| 106 | Thin bony cortex (HP:0002753) | 2.02517297 |
| 107 | Spinal muscular atrophy (HP:0007269) | 2.02407824 |
| 108 | Diminished motivation (HP:0000745) | 1.99648403 |
| 109 | Flared iliac wings (HP:0002869) | 1.98667744 |
| 110 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.98575385 |
| 111 | Protrusio acetabuli (HP:0003179) | 1.97430308 |
| 112 | Hydroxyprolinuria (HP:0003080) | 1.96277262 |
| 113 | Abnormality of proline metabolism (HP:0010907) | 1.96277262 |
| 114 | Aortic aneurysm (HP:0004942) | 1.95738646 |
| 115 | Wide anterior fontanel (HP:0000260) | 1.95391975 |
| 116 | Vascular tortuosity (HP:0004948) | 1.95084545 |
| 117 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.93729024 |
| 118 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.93362248 |
| 119 | Polycythemia (HP:0001901) | 1.92663585 |
| 120 | Wrist flexion contracture (HP:0001239) | 1.92152684 |
| 121 | J-shaped sella turcica (HP:0002680) | 1.92020858 |
| 122 | Asymmetric septal hypertrophy (HP:0001670) | 1.91917924 |
| 123 | Hepatosplenomegaly (HP:0001433) | 1.90842296 |
| 124 | Optic neuritis (HP:0100653) | 1.89301150 |
| 125 | Retrobulbar optic neuritis (HP:0100654) | 1.89301150 |
| 126 | Increased connective tissue (HP:0009025) | 1.89110674 |
| 127 | Personality changes (HP:0000751) | 1.88729608 |
| 128 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87224696 |
| 129 | Bruising susceptibility (HP:0000978) | 1.86492094 |
| 130 | Round ear (HP:0100830) | 1.85203556 |
| 131 | Absent frontal sinuses (HP:0002688) | 1.84675525 |
| 132 | Nonimmune hydrops fetalis (HP:0001790) | 1.84610089 |
| 133 | Proximal tubulopathy (HP:0000114) | 1.83923672 |
| 134 | Spondylolisthesis (HP:0003302) | 1.83458864 |
| 135 | Mitral regurgitation (HP:0001653) | 1.83412185 |
| 136 | Protuberant abdomen (HP:0001538) | 1.81020996 |
| 137 | Tetraparesis (HP:0002273) | 1.79569110 |
| 138 | Abnormality of skull ossification (HP:0002703) | 1.78972113 |
| 139 | Premature loss of primary teeth (HP:0006323) | 1.77970783 |
| 140 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.77950617 |
| 141 | Bowel diverticulosis (HP:0005222) | 1.76485079 |
| 142 | Ovoid vertebral bodies (HP:0003300) | 1.75490640 |
| 143 | Biconcave vertebral bodies (HP:0004586) | 1.75180997 |
| 144 | Stomatitis (HP:0010280) | 1.72652769 |
| 145 | White forelock (HP:0002211) | 1.71529494 |
| 146 | Striae distensae (HP:0001065) | 1.71455405 |
| 147 | Distal lower limb muscle weakness (HP:0009053) | 1.70628840 |
| 148 | Peritonitis (HP:0002586) | 1.70172296 |
| 149 | Femoral bowing (HP:0002980) | 1.70020248 |
| 150 | Inappropriate behavior (HP:0000719) | 1.69746543 |
| 151 | Disproportionate tall stature (HP:0001519) | 1.69320847 |
| 152 | Thoracic kyphosis (HP:0002942) | 1.68533794 |
| 153 | Joint hemorrhage (HP:0005261) | 1.67407656 |
| 154 | Osteomyelitis (HP:0002754) | 1.67298580 |
| 155 | Poor head control (HP:0002421) | 1.67244970 |
| 156 | Recurrent fungal infections (HP:0002841) | 1.67102665 |
| 157 | Retinal atrophy (HP:0001105) | 1.66984813 |
| 158 | Mucosal telangiectasiae (HP:0100579) | 1.66823917 |
| 159 | Arterial thrombosis (HP:0004420) | 1.66069005 |
| 160 | Urticaria (HP:0001025) | 1.65789415 |
| 161 | Metaphyseal cupping (HP:0003021) | 1.63125612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYLK | 4.85315339 |
| 2 | BLK | 4.59182059 |
| 3 | TGFBR2 | 4.01156659 |
| 4 | ERN1 | 3.10842222 |
| 5 | TYK2 | 2.82479474 |
| 6 | IRAK3 | 2.82046418 |
| 7 | TBK1 | 2.60067494 |
| 8 | CAMK1D | 2.48205737 |
| 9 | MAP3K14 | 2.42211231 |
| 10 | KIT | 2.36939965 |
| 11 | NEK9 | 2.36258444 |
| 12 | AKT3 | 2.24901108 |
| 13 | PIK3CG | 2.18458833 |
| 14 | PDK2 | 2.07186235 |
| 15 | SCYL2 | 2.02095180 |
| 16 | LIMK1 | 1.98915921 |
| 17 | TTN | 1.95565158 |
| 18 | TRIB3 | 1.95470454 |
| 19 | STK10 | 1.84917693 |
| 20 | IRAK4 | 1.80780173 |
| 21 | CAMK1G | 1.74000415 |
| 22 | EPHB1 | 1.72781089 |
| 23 | RIPK4 | 1.72018243 |
| 24 | JAK1 | 1.58843197 |
| 25 | CSF1R | 1.58800631 |
| 26 | MAP3K3 | 1.51255796 |
| 27 | IKBKB | 1.51244588 |
| 28 | RIPK1 | 1.43830151 |
| 29 | KDR | 1.43745799 |
| 30 | ZAP70 | 1.43707626 |
| 31 | CDC42BPA | 1.36021382 |
| 32 | MAP2K3 | 1.34369927 |
| 33 | PAK4 | 1.30147843 |
| 34 | LATS2 | 1.29366321 |
| 35 | PTK6 | 1.28265352 |
| 36 | MAP4K1 | 1.24360689 |
| 37 | PRKD2 | 1.21928917 |
| 38 | PIM2 | 1.20608401 |
| 39 | STK3 | 1.18751217 |
| 40 | HCK | 1.18707267 |
| 41 | ACVR1B | 1.17459062 |
| 42 | TAOK3 | 1.17238528 |
| 43 | BMX | 1.15974403 |
| 44 | PKN2 | 1.15166329 |
| 45 | IKBKE | 1.13282367 |
| 46 | CHUK | 1.09993766 |
| 47 | NME2 | 1.09718568 |
| 48 | CSK | 1.09267660 |
| 49 | ADRBK1 | 1.03596085 |
| 50 | STK38 | 1.03450492 |
| 51 | LRRK2 | 1.02749456 |
| 52 | EPHA3 | 1.00043957 |
| 53 | MOS | 0.99504211 |
| 54 | ABL2 | 0.98985283 |
| 55 | CDK6 | 0.98254846 |
| 56 | FER | 0.97923195 |
| 57 | NTRK1 | 0.97183438 |
| 58 | PRKG2 | 0.95220210 |
| 59 | GRK7 | 0.94748728 |
| 60 | ILK | 0.94007540 |
| 61 | MAPKAPK3 | 0.93723109 |
| 62 | DAPK3 | 0.92226148 |
| 63 | WNK4 | 0.91938869 |
| 64 | JAK3 | 0.91677323 |
| 65 | RPS6KA4 | 0.91483210 |
| 66 | LYN | 0.89939377 |
| 67 | FGR | 0.89064722 |
| 68 | ERBB4 | 0.87526129 |
| 69 | JAK2 | 0.87416213 |
| 70 | EGFR | 0.85849573 |
| 71 | GRK5 | 0.85593430 |
| 72 | CAMKK2 | 0.84893437 |
| 73 | BMPR2 | 0.83956874 |
| 74 | MAPK7 | 0.83238140 |
| 75 | TIE1 | 0.82767584 |
| 76 | PRKD1 | 0.81725614 |
| 77 | ROCK1 | 0.80758785 |
| 78 | MAP3K6 | 0.77636420 |
| 79 | PIM1 | 0.75652440 |
| 80 | PBK | 0.74782230 |
| 81 | MAP3K12 | 0.74637550 |
| 82 | DMPK | 0.73249161 |
| 83 | FGFR4 | 0.72113357 |
| 84 | LCK | 0.70802820 |
| 85 | EIF2AK2 | 0.69097994 |
| 86 | FES | 0.68499699 |
| 87 | TRPM7 | 0.68436145 |
| 88 | MAP2K1 | 0.68165585 |
| 89 | PTK2 | 0.68125397 |
| 90 | PLK2 | 0.67577168 |
| 91 | DDR2 | 0.67023154 |
| 92 | LATS1 | 0.66298886 |
| 93 | TEC | 0.65637957 |
| 94 | GSK3A | 0.65628185 |
| 95 | MELK | 0.65334472 |
| 96 | ABL1 | 0.65289548 |
| 97 | TAOK2 | 0.65264943 |
| 98 | PDPK1 | 0.64479729 |
| 99 | NUAK1 | 0.64086555 |
| 100 | FLT3 | 0.63598039 |
| 101 | RPS6KA2 | 0.61366136 |
| 102 | SIK1 | 0.61104289 |
| 103 | PTK2B | 0.60590257 |
| 104 | PDGFRB | 0.59700014 |
| 105 | ICK | 0.57494078 |
| 106 | PAK1 | 0.56312059 |
| 107 | BTK | 0.56130690 |
| 108 | PAK2 | 0.56057463 |
| 109 | MARK3 | 0.56013201 |
| 110 | ADRBK2 | 0.55977372 |
| 111 | CLK1 | 0.55743050 |
| 112 | IGF1R | 0.55376337 |
| 113 | ROCK2 | 0.54953210 |
| 114 | EIF2AK1 | 0.54014091 |
| 115 | MAPK12 | 0.53477322 |
| 116 | TXK | 0.53190668 |
| 117 | ITK | 0.52197292 |
| 118 | WNK3 | 0.51984004 |
| 119 | PDGFRA | 0.51740466 |
| 120 | EPHA2 | 0.50514195 |
| 121 | CDK12 | 0.49592996 |
| 122 | FGFR3 | 0.49290908 |
| 123 | MAP3K13 | 0.47806259 |
| 124 | SYK | 0.47753555 |
| 125 | MAP3K8 | 0.47032684 |
| 126 | MET | 0.46000094 |
| 127 | * PRKCD | 0.45868277 |
| 128 | MATK | 0.44781606 |
| 129 | SRC | 0.43913019 |
| 130 | MTOR | 0.42618527 |
| 131 | MST1R | 0.41911636 |
| 132 | STK4 | 0.40051790 |
| 133 | EPHB2 | 0.39135643 |
| 134 | INSR | 0.39055571 |
| 135 | CAMKK1 | 0.37227970 |
| 136 | MAP3K5 | 0.36885404 |
| 137 | PRKCH | 0.36484321 |
| 138 | TESK1 | 0.36240497 |
| 139 | SGK3 | 0.35584751 |
| 140 | TGFBR1 | 0.34174152 |
| 141 | LMTK2 | 0.33430891 |
| 142 | MST4 | 0.32853608 |
| 143 | MAPKAPK2 | 0.32016398 |
| 144 | PRKAA2 | 0.29803307 |
| 145 | CAMK2G | 0.29298975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.15559687 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.93270525 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.45135079 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.20096238 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.55512133 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.30090188 |
| 7 | Phagosome_Homo sapiens_hsa04145 | 2.26737910 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23465770 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.20898400 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.17194513 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.13903493 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.97364718 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.88139648 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65890539 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.60063462 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.58693011 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 1.50956213 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47576146 |
| 19 | Shigellosis_Homo sapiens_hsa05131 | 1.41304235 |
| 20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.40438047 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.36659953 |
| 22 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34167728 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.32714361 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.32298973 |
| 25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.32098251 |
| 26 | Amoebiasis_Homo sapiens_hsa05146 | 1.29082242 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.25978661 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.25492066 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.25329903 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.24187116 |
| 31 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.21841798 |
| 32 | Mineral absorption_Homo sapiens_hsa04978 | 1.20957614 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.20904267 |
| 34 | Bladder cancer_Homo sapiens_hsa05219 | 1.20297182 |
| 35 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.19498032 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19173231 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18460787 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.17974342 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.16792660 |
| 40 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.15281800 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.10852176 |
| 42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.09681575 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.09626261 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.08756956 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08387059 |
| 46 | Melanoma_Homo sapiens_hsa05218 | 1.06610954 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.04004147 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02527315 |
| 49 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.00845208 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.93747234 |
| 51 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93554094 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92460078 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90289200 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90147083 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89747493 |
| 56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.89534932 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 0.88287615 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.87403302 |
| 59 | * Endocytosis_Homo sapiens_hsa04144 | 0.86846676 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.86428795 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84429963 |
| 62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84072993 |
| 63 | Prion diseases_Homo sapiens_hsa05020 | 0.83444940 |
| 64 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.82945477 |
| 65 | Gap junction_Homo sapiens_hsa04540 | 0.82526568 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82454096 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81004903 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80982077 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.80940843 |
| 70 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.80810149 |
| 71 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.79583721 |
| 72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.79405797 |
| 73 | Pathways in cancer_Homo sapiens_hsa05200 | 0.79036022 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79010667 |
| 75 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.76855152 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.76615072 |
| 77 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.76225994 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.75543947 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74426518 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73212635 |
| 81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.70705202 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70454642 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69907333 |
| 84 | Allograft rejection_Homo sapiens_hsa05330 | 0.66845754 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65980815 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65019888 |
| 87 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62978194 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59964172 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.59878712 |
| 90 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57559437 |
| 91 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57162701 |
| 92 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55779808 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55555225 |
| 94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54939516 |
| 95 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52995675 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52595253 |
| 97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.52367564 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.51284155 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49218048 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.48354916 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47055675 |
| 102 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46343214 |
| 103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44496185 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43555055 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42385699 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41458144 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40419249 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39867884 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39854922 |
| 110 | Melanogenesis_Homo sapiens_hsa04916 | 0.38360674 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.37155507 |
| 112 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.36913460 |
| 113 | Prostate cancer_Homo sapiens_hsa05215 | 0.33222001 |
| 114 | Lysine degradation_Homo sapiens_hsa00310 | 0.31809432 |
| 115 | Tight junction_Homo sapiens_hsa04530 | 0.31743495 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30055653 |
| 117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29539085 |
| 118 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.28781774 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26593540 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25915683 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25805634 |
| 122 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.25179778 |
| 123 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.23966535 |
| 124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.23519085 |
| 125 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.22976091 |
| 126 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.21559295 |
| 127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20980934 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20805846 |
| 129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.18761271 |

